Fig. 3From: 1-year results of combined half-dose photodynamic therapy and ranibizumab for polypoidal choroidal vasculopathyThis was the indocyanine green angiogram of subject 6. Baseline logMAR visual acuity was 0.1, and remained at 0.1 throughout. There was only 1 single polyp, which regressed after only one session of half-dose photodynamic therapy and one injection of ranibizumab. a Showed the appearance of the polyp at baseline on ICG; and b the appearance at 3 monthsBack to article page